Recently, compelling evidence has surfaced that PHLPP1 and PHLPP2 function as tumor suppressor genes, with frequent depletion of their expression observed in various types of human cancers including CRC (Li et al., 2014[34]; O'Neill et al., 2013[48]). The gene discussed is PHLPP2; the disease is cancer.